Search icon

RELMADA THERAPEUTICS, INC.

Headquarter

Company Details

Name: RELMADA THERAPEUTICS, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 21 Feb 2014 (11 years ago)
Entity Number: 4533249
ZIP code: 33134
County: New York
Place of Formation: Delaware
Address: 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL, United States, 33134

DOS Process Agent

Name Role Address
RELMADA THERAPEUTICS, INC. DOS Process Agent 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL, United States, 33134

Chief Executive Officer

Name Role Address
SERGIO TRAVERSA Chief Executive Officer 2222 PONCE DE LEON BLVD., FLOOR 3, CORAL GABLES, FL, United States, 33134

Links between entities

Type:
Headquarter of
Company Number:
20201014287
State:
COLORADO

Form 5500 Series

Employer Identification Number (EIN):
208506626
Plan Year:
2020
Number Of Participants:
9
Sponsors Telephone Number:
Plan Year:
2019
Number Of Participants:
6
Sponsors Telephone Number:
Plan Year:
2018
Number Of Participants:
6
Sponsors Telephone Number:
Plan Year:
2017
Number Of Participants:
9
Sponsors Telephone Number:
Plan Year:
2016
Number Of Participants:
14
Sponsors Telephone Number:

History

Start date End date Type Value
2024-08-29 2024-08-29 Address 275 MADISON AVENUE, STE #702, NEW YORK, NY, 10016, USA (Type of address: Chief Executive Officer)
2024-08-29 2024-08-29 Address 2222 PONCE DE LEON BLVD., FLOOR 3, CORAL GABLES, FL, 33134, USA (Type of address: Chief Executive Officer)
2023-10-12 2024-08-29 Address 2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL, 33134, USA (Type of address: Service of Process)
2023-10-12 2024-08-29 Address 275 MADISON AVENUE, STE #702, NEW YORK, NY, 10016, USA (Type of address: Chief Executive Officer)
2023-10-12 2023-10-12 Address 2222 PONCE DE LEON BLVD., FLOOR 3, CORAL GABLES, FL, 33134, USA (Type of address: Chief Executive Officer)

Filings

Filing Number Date Filed Type Effective Date
240829000882 2024-08-29 BIENNIAL STATEMENT 2024-08-29
231012002245 2023-10-12 BIENNIAL STATEMENT 2022-02-01
200203060889 2020-02-03 BIENNIAL STATEMENT 2020-02-01
191106060362 2019-11-06 BIENNIAL STATEMENT 2018-02-01
161116006049 2016-11-16 BIENNIAL STATEMENT 2016-02-01

Trademarks Section

Serial Number:
88039453
Mark:
SECUREL
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2018-07-16
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SECUREL

Goods And Services

For:
Drug delivery agents consisting of compounds that facilitate controlled delivery of pharmaceuticals for the prevention and treatment of pain
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
86475457
Mark:
SECUREL
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2014-12-09
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SECUREL

Goods And Services

For:
DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE CONTROL-LED DELIVERY OF PHARMACEUTICALS FOR THE PREVENTION AND TREATMENT OF PAIN
International Classes:
005 - Primary Class
Class Status:
Active

Court Cases

Court Case Summary

Filing Date:
2016-10-05
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Both plaintiff and defendant demand jury
Nature Of Suit:
Securities, Commodities, Exchange

Parties

Party Name:
RELMADA THERAPEUTICS, INC.
Party Role:
Plaintiff
Party Name:
LAIDLAW & COMPANY (UK) ,
Party Role:
Defendant

Date of last update: 25 Mar 2025

Sources: New York Secretary of State